Diffusion-weighted magnetic resonance imaging (DWMRI) of head and neck squamous cell carcinoma: could it be an imaging biomarker for prediction of response to chemoradiation therapy

Abstract Background Chemoradiation therapy (CRT) has become a primary definitive treatment modality for head and neck squamous cell carcinoma (HNSCC); however, not all patients respond completely to treatment. Ability to identify those patients, who would not achieve complete response, before or ear...

Full description

Bibliographic Details
Main Authors: Hanan Mohamed Khattab, Moataz Mohamed Montasser, Mohamed Eid, Alaa Kandil, Salah El-Din Desouky
Format: Article
Language:English
Published: SpringerOpen 2020-10-01
Series:The Egyptian Journal of Radiology and Nuclear Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s43055-020-00323-x
_version_ 1828895155940229120
author Hanan Mohamed Khattab
Moataz Mohamed Montasser
Mohamed Eid
Alaa Kandil
Salah El-Din Desouky
author_facet Hanan Mohamed Khattab
Moataz Mohamed Montasser
Mohamed Eid
Alaa Kandil
Salah El-Din Desouky
author_sort Hanan Mohamed Khattab
collection DOAJ
description Abstract Background Chemoradiation therapy (CRT) has become a primary definitive treatment modality for head and neck squamous cell carcinoma (HNSCC); however, not all patients respond completely to treatment. Ability to identify those patients, who would not achieve complete response, before or early during the course of CRT will allow treatment modifications to improve outcome and overall survival. The aim of this prospective study was to assess the usefulness of diffusion-weighted imaging (DWI) in prediction of early therapeutic response of HNSCC after CRT. Results Local control was achieved in 22 patients out of 46 patients with pathologically proven HNSCC treated by chemoradiation therapy and local failure was detected in 24 patients out of 46 patients. Pretreatment mean apparent diffusion coefficient (ADCpre) was significantly higher in local failure group (1.1 ± 0.2 × 10−3 mm2/s) than local control group (0.89 ± 0.1 × 10−3 mm2/s). An optimal cut-off value of more than 0.94 × 10−3 mm2/s was predictive of local failure with sensitivity 83.33%, specificity 59.9%, PPV 69%, NPV 76.5%. Early intra-treatment percentage change of ADC (ΔADC) was significantly lower in local failure group (21.8% ± 21.3) than in local control group (45.2% ± 27.8). An optimal cut-off value of ≤ 33% was predictive of local failure after CRT with sensitivity of 71.34%, specificity of 60%, PPV of 62.5%, and NPV of 69.2%. Conclusions Diffusion-weighted MRI could be a potential predictive biomarker for therapeutic response of HNSCC to CRT. Primary tumors with higher pretreatment mean ADC, and a smaller early intratreatment percentage increase of mean ADC would be more likely to fail treatment.
first_indexed 2024-12-13T14:23:59Z
format Article
id doaj.art-6f74ff67084e4d8ab7daa386d2dff8c6
institution Directory Open Access Journal
issn 2090-4762
language English
last_indexed 2024-12-13T14:23:59Z
publishDate 2020-10-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Radiology and Nuclear Medicine
spelling doaj.art-6f74ff67084e4d8ab7daa386d2dff8c62022-12-21T23:41:59ZengSpringerOpenThe Egyptian Journal of Radiology and Nuclear Medicine2090-47622020-10-0151111410.1186/s43055-020-00323-xDiffusion-weighted magnetic resonance imaging (DWMRI) of head and neck squamous cell carcinoma: could it be an imaging biomarker for prediction of response to chemoradiation therapyHanan Mohamed Khattab0Moataz Mohamed Montasser1Mohamed Eid2Alaa Kandil3Salah El-Din Desouky4Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Alexandria UniversityDepartment of Diagnostic and Interventional Radiology, Faculty of Medicine, Alexandria UniversityDepartment of Diagnostic and Interventional Radiology, Faculty of Medicine, Alexandria UniversityDepartment of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Alexandria UniversityDepartment of Diagnostic and Interventional Radiology, Faculty of Medicine, Alexandria UniversityAbstract Background Chemoradiation therapy (CRT) has become a primary definitive treatment modality for head and neck squamous cell carcinoma (HNSCC); however, not all patients respond completely to treatment. Ability to identify those patients, who would not achieve complete response, before or early during the course of CRT will allow treatment modifications to improve outcome and overall survival. The aim of this prospective study was to assess the usefulness of diffusion-weighted imaging (DWI) in prediction of early therapeutic response of HNSCC after CRT. Results Local control was achieved in 22 patients out of 46 patients with pathologically proven HNSCC treated by chemoradiation therapy and local failure was detected in 24 patients out of 46 patients. Pretreatment mean apparent diffusion coefficient (ADCpre) was significantly higher in local failure group (1.1 ± 0.2 × 10−3 mm2/s) than local control group (0.89 ± 0.1 × 10−3 mm2/s). An optimal cut-off value of more than 0.94 × 10−3 mm2/s was predictive of local failure with sensitivity 83.33%, specificity 59.9%, PPV 69%, NPV 76.5%. Early intra-treatment percentage change of ADC (ΔADC) was significantly lower in local failure group (21.8% ± 21.3) than in local control group (45.2% ± 27.8). An optimal cut-off value of ≤ 33% was predictive of local failure after CRT with sensitivity of 71.34%, specificity of 60%, PPV of 62.5%, and NPV of 69.2%. Conclusions Diffusion-weighted MRI could be a potential predictive biomarker for therapeutic response of HNSCC to CRT. Primary tumors with higher pretreatment mean ADC, and a smaller early intratreatment percentage increase of mean ADC would be more likely to fail treatment.http://link.springer.com/article/10.1186/s43055-020-00323-xHead and neck squamous cell carcinomaDiffusion-weighted MRIChemoradiation therapy
spellingShingle Hanan Mohamed Khattab
Moataz Mohamed Montasser
Mohamed Eid
Alaa Kandil
Salah El-Din Desouky
Diffusion-weighted magnetic resonance imaging (DWMRI) of head and neck squamous cell carcinoma: could it be an imaging biomarker for prediction of response to chemoradiation therapy
The Egyptian Journal of Radiology and Nuclear Medicine
Head and neck squamous cell carcinoma
Diffusion-weighted MRI
Chemoradiation therapy
title Diffusion-weighted magnetic resonance imaging (DWMRI) of head and neck squamous cell carcinoma: could it be an imaging biomarker for prediction of response to chemoradiation therapy
title_full Diffusion-weighted magnetic resonance imaging (DWMRI) of head and neck squamous cell carcinoma: could it be an imaging biomarker for prediction of response to chemoradiation therapy
title_fullStr Diffusion-weighted magnetic resonance imaging (DWMRI) of head and neck squamous cell carcinoma: could it be an imaging biomarker for prediction of response to chemoradiation therapy
title_full_unstemmed Diffusion-weighted magnetic resonance imaging (DWMRI) of head and neck squamous cell carcinoma: could it be an imaging biomarker for prediction of response to chemoradiation therapy
title_short Diffusion-weighted magnetic resonance imaging (DWMRI) of head and neck squamous cell carcinoma: could it be an imaging biomarker for prediction of response to chemoradiation therapy
title_sort diffusion weighted magnetic resonance imaging dwmri of head and neck squamous cell carcinoma could it be an imaging biomarker for prediction of response to chemoradiation therapy
topic Head and neck squamous cell carcinoma
Diffusion-weighted MRI
Chemoradiation therapy
url http://link.springer.com/article/10.1186/s43055-020-00323-x
work_keys_str_mv AT hananmohamedkhattab diffusionweightedmagneticresonanceimagingdwmriofheadandnecksquamouscellcarcinomacoulditbeanimagingbiomarkerforpredictionofresponsetochemoradiationtherapy
AT moatazmohamedmontasser diffusionweightedmagneticresonanceimagingdwmriofheadandnecksquamouscellcarcinomacoulditbeanimagingbiomarkerforpredictionofresponsetochemoradiationtherapy
AT mohamedeid diffusionweightedmagneticresonanceimagingdwmriofheadandnecksquamouscellcarcinomacoulditbeanimagingbiomarkerforpredictionofresponsetochemoradiationtherapy
AT alaakandil diffusionweightedmagneticresonanceimagingdwmriofheadandnecksquamouscellcarcinomacoulditbeanimagingbiomarkerforpredictionofresponsetochemoradiationtherapy
AT salaheldindesouky diffusionweightedmagneticresonanceimagingdwmriofheadandnecksquamouscellcarcinomacoulditbeanimagingbiomarkerforpredictionofresponsetochemoradiationtherapy